닫기

홈>Company>Leadership

Leadership

Sang Gyu Park
Founder & CEO
Sang Gyu Park

Sang Gyu is a senior scientist with 20 years of experience in protein and antibody research. Up to now, he has designed more than 200 antibodies and achieved hands-on knowhow in immunization and affinity maturation, which became the impetus of Novelty Nobility’s pipeline development. Sang Gyu is an incumbent professor of pharmacy at Ajou University and received a Ph.D. in pharmacy from Seoul National University. He currently serves as an editorial board member of Scientific Reports.

Jin Cho
CFO
Jin Cho

Jin leads finance and business activities at Novelty Nobility. He is an experienced professional in fundraising and operations at a biotech company and is skillful at translating science into business, and vice versa. At Novelty Nobility, Jin is mostly interested in building a corporate culture that woos talented and decent people, while he himself spends most of the time in crunching numbers and reviewing contracts. He received an MBA from MIT Sloan School of Management.

Min-Duk Seo
CTO
Min-Duk Seo

Min-Duk is an experienced scientist in the field of protein research, including protein purification, characterization, and structural determination. He is interested in the structures of biological macromolecules to elucidate structure-function relationship and has determined three-dimensional structures of various proteins, such as calcium channel and antibody. Min-Duk is an incumbent professor of pharmacy at Ajou University and received a Ph.D. in pharmacy from Seoul National University.

Yuni Jung
Head of CMC
Yuni Jung

Yuni is a biologics CMC veteran with 20 years of experience who provides expertise and leadership spanning the entire cycle of new drug development. A great communicator and hands-on developer, she works closely with external CDMO/CRO partners to ensure effective and consistent product quality control. She received a Ph.D. in medical biochemistry from Texas A&M University under Dr. Hagan Bayley’s supervision and worked as a postdoctoral scientist at UCSF in a project involving structure-based engineering of membrane channels.